Preclinical results indicated the more potent anti-inflammatory (2.5 fold) and anti-tumor (4.3 fold) effects of 100 than the parent 9765, which provided a new direction for developing IKKβ inhibitors. This evidence concerns the gene IKBKB and neoplasm.